CMS Medicare Center Director Seshamani Will Steer Coverage Decision On Aduhelm
Meena Seshamani served in the Obama Administration as head of the health reform office within the Health and Human Services Department.
You may also be interested in...
US FDA’s apolitical leadership team is highly unusual – but is it a strength or a weakness in a new Administration? Acting Commissioner Janet Woodcock has been running the agency for nearly six months and there are no signs of the status quo changing any time soon.
After months of reticence about his Administration's plans for tackling drug pricing, Biden's executive order offers some clues about what might be in store and what kind of timeline they are working with.
Tsai will likely participate in a decision on whether to allow Tennessee to move ahead with changes to its Medicaid program that might include the flexibility to exclude drugs from coverage.